Literature DB >> 198372

Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans.

E J Shillitoe, J M Wilton, T Lehner.   

Abstract

Lymphocyte responses to herpes simplex virus (HSV) were studied in 23 patients with recurrent herpes labialis and in 19 control subjects. Lymphocytes of seropositive, but not seronegative, controls responded to HSV by thymidine incorporation, and the supernatant fluids inhibited the migration of guinea pig macrophages. Lymphocytes from patients with a recurrent herpetic lesion responded to HSV by significantly greater thymidine incorporation than seropositive controls, but supernatants did not show an increased macrophage migration inhibition response. During the 28 days after the onset of a lesion, the thymidine incorporation to HSV fell to the level of the seropositive controls, and supernatants then induced an increased inhibition of macrophage migration. Lymphocyte responses to Candida albicans, purified protein derivative, or phytohemagglutinin did not fluctuate according to the presence of a lesion and did not differ from those of the controls. Lymphocyte responses to HSV were unaffected by culture in the presence of serum from seronegative or seropositive controls, or from patients with or without a herpetic lesion. It is suggested that in patients with recurrent herpes labialis a periodic defect of the migration inhibition response might have allowed the recurrent infection to develop, and that the increased thymidine incorporation stimulated by HSV in vitro is a result of antigenic stimulation from the lesion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 198372      PMCID: PMC421204          DOI: 10.1128/iai.18.1.130-137.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Technique of complementfixation test applicable to the diagnosis of virus diseases.

Authors:  C M BRADSTREET; C E TAYLOR
Journal:  Mon Bull Minist Health Public Health Lab Serv       Date:  1962-05

2.  Serologic investigations of herpes simplex virus infections.

Authors:  H E DASCOMB; C V ADAIR; N ROGERS
Journal:  J Lab Clin Med       Date:  1955-07

3.  Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.

Authors:  R J O'Reilly; A Chibbaro; E Anger; C Lopez
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

4.  Lymphocyte interferon production and transformation after Herpes simplex infections in humans.

Authors:  L E Rasmussen; G W Jordan; D A Stevens; T C Merigan
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Macrophages and age-dependent resistance to Herpes simplex virus in mice.

Authors:  M S Hirsch; B Zisman; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

6.  Depression of established delayed hepersensitivity by mumps virus.

Authors:  C B Hall; F S Kantor
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

7.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Production of chemotactic factor and lymphotoxin by human leukocytes stimulated with Herpes simplex virus.

Authors:  G L Rosenberg; R Snyderman; A L Notkins
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

9.  Cell-mediated immunity to herpes simplex virus types 1 and 2 antigens in leukoplakia and carcinoma in man.

Authors:  E J Shillitoe; G Tarro; T Lehner
Journal:  Oncology       Date:  1976       Impact factor: 2.935

10.  Characterization of a lymphocyte factor which alters macrophage functions.

Authors:  C F Nathan; H G Remold; J R David
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  13 in total

1.  Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.

Authors:  J P Vestey; M Norval; S Howie; J Maingay; W A Neill
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

2.  Regulation of herpes simplex virus-specific lymphoproliferation by suppressor cells.

Authors:  D W Horohov; R N Moore; B T Rouse
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

3.  Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans.

Authors:  L Rasmussen; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 4.  Recurrent genital tract infection: a result of induced immunosuppression?

Authors:  C Sonnex
Journal:  Genitourin Med       Date:  1989-12

5.  Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation.

Authors:  M C Rattray; G M Peterman; L C Altman; L Corey; K K Holmes
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

6.  Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity.

Authors:  A A Nash; P G Gell; P Wildy
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

7.  Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens.

Authors:  K O Kalimo; I A Joronen; V K Havu
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

8.  Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.

Authors:  A D Donnenberg; E Chaikof; L Aurelian
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

9.  Animal studies on the efficacy of vaccination against recurrent herpes.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

10.  Secondary herpes simplex virus latent infection in transplanted ganglia.

Authors:  R B Tenser; W A Edris; A Gaydos; K A Hay
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.